E. Berendes et al., EFFECTS OF DOPEXAMINE ON CREATININE CLEARANCE, SYSTEMIC INFLAMMATION,AND SPLANCHNIC OXYGENATION IN PATIENTS UNDERGOING CORONARY-ARTERY BYPASS-GRAFTING, Anesthesia and analgesia, 84(5), 1997, pp. 950-957
Impairment of splanchnic and peripheral tissue perfusion during cardio
pulmonary bypass (CPB) may be responsible for endotoxin-mediated syste
mic inflammation and acute phase responses. We examined the effects of
dopexamine on hemodynamic parameters, creatinine clearance, systemic
and splanchnic oxygenation, gastric mucosal pH (pHi), and mixed and he
patic venous plasma levels of endotoxin, interleukin-6 (IL-6), serum a
myloid A (SAA), and C-reactive protein (CRP) in 44 patients scheduled
for coronary artery bypass grafting. Patients were randomized to recei
ve continuous infusions of 0.5, 1.0, or 2 mu g.kg(-1) min(-1) dopexami
ne (n = 10 per group) or placebo (n = 14) prior to surgery, intraopera
tively, and postoperatively. Dopexamine infusion increased systemic ox
ygen delivery (P less than or equal to 0.01). Hepatic venous oxygen sa
turation did not change, and pi-Ii decreased during and after CPB in a
ll patients (P less than or equal to 0.01). Postoperative increases in
IL-6 were smallest in patients who received 2.0 mu g.kg(-1).min(-1) d
opexamine (P less than or equal to 0.02). SAA and CRP increases during
the postoperative period were less pronounced with dopexamine through
out the study. Creatinine clearance was elevated in all dopexamine gro
ups (P less than or equal to 0.025). This elevation was higher with lo
wer dopexamine doses (P less than or equal to 0.025). We conclude that
dopexamine improves creatinine clearance and reduces systemic inflamm
ation without affecting splanchnic oxygenation.